DNA X, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.2M | $6.3M | $-8.9M | $-4.8M | $-7.5M | $458.0K | $-21.6M | $-2.5M |
| Depreciation & Amortization | — | — | $1.5M | $952.0K | $797.0K | $1.1M | $914.0K | $918.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $98.0K | $304.0K | $159.0K | $166.0K | $926.0K | $290.0K | $356.0K | $373.0K |
| Net Cash from Operating Activities | $-2.0M | $-3.5M | $-2.0M | $-7.0M | $-4.9M | $-9.6M | $-4.5M | $-417.0K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | $8.0K | $137.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-94.0K | $3.4M | — | — | — | — | $-8.0K | $-137.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $1.2M | $7.2M | $4.8M | $6.4M | $800.0K | $14.0K |
| Net Change in Cash | $-295.0K | $-108.0K | $-834.0K | $131.0K | $-109.0K | $-3.2M | $-3.7M | $-540.0K |
| Free Cash Flow | — | — | — | — | — | — | $-4.5M | $-554.0K |